Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Secretary & VP Finance & Admin

President & CEO

Interim Executive Chairman

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	Secretary & VP Finance & Admin
2024-02-26	Premium	bought	Premium	Premium	Premium	President & CEO
2024-02-20	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2024-02-17	Premium	sold (taxes)	Premium	Premium	Premium	Secretary & VP Finance & Admin
2024-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Secretary & VP Finance & Admin
2023-10-01	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2023-07-01	Premium	bought	Premium	Premium	Premium	President & CEO
2023-06-30	Premium	bought	Premium	Premium	Premium	President & CEO
2023-06-14	Premium	bought	Premium	Premium	Premium	-
2023-03-01	Premium	sold (taxes)	Premium	Premium	Premium	Secretary & VP Finance & Admin
2023-02-20	Premium	acquired	Premium	Premium	Premium	President & CEO
2023-02-17	Premium	acquired	Premium	Premium	Premium	-
2023-02-17	Premium	acquired	Premium	Premium	Premium	-
2023-02-17	Premium	acquired	Premium	Premium	Premium	-
2023-02-17	Premium	acquired	Premium	Premium	Premium	Secretary & VP Finance & Admin
2023-02-17	Premium	acquired	Premium	Premium	Premium	-
2023-02-17	Premium	acquired	Premium	Premium	Premium	-
2023-02-15	Premium	sold (taxes)	Premium	Premium	Premium	Secretary & VP Finance & Admin
2022-12-14	Premium	bought	Premium	Premium	Premium	Interim Executive Chairman
2022-12-07	Premium	bought	Premium	Premium	Premium	Interim Executive Chairman
2022-12-05	Premium	bought	Premium	Premium	Premium	Interim Executive Chairman
2022-12-02	Premium	bought	Premium	Premium	Premium	-
2022-11-29	Premium	bought	Premium	Premium	Premium	Interim Executive Chairman
2022-11-25	Premium	bought	Premium	Premium	Premium	Interim Executive Chairman
2022-11-23	Premium	bought	Premium	Premium	Premium	-

PHIO - Phio Pharmaceuticals Corp Stock Price, Fair Value and News

Latest Insider Trading transactions for PHIO